These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13753032)

  • 1. Biological activity of synthetic polypeptides with bradykinin-like properties.
    KONZETT H; STURMER E
    Br J Pharmacol Chemother; 1960 Dec; 15(4):544-51. PubMed ID: 13753032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and properties of new bradykinin potentiating peptides.
    Tominaga M; Stewart JM
    J Med Chem; 1975 Feb; 18(2):130-3. PubMed ID: 1120978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological and biochemical properties of a kallikrein-like enzyme from the venom of Vipera aspis aspis (aspic viper).
    Komori Y; Sugihara H
    Toxicon; 1988; 26(12):1193-203. PubMed ID: 3238703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein generates angiotensin II but not bradykinin in the plasma of the urodele, Amphiuma tridactylum.
    Conlon JM; Yano K
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Mar; 110(3):305-11. PubMed ID: 7599980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two kinins formed by trypsin from human plasma protein.
    Okuda M; Arakawa K
    J Biochem; 1982 Feb; 91(2):633-41. PubMed ID: 7068581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [(Patho-)physiology and pharmacology of bradykinin and other plasma kinins. I].
    Ufkes JG; van der Meer C
    Ned Tijdschr Geneeskd; 1976 Jan; 120(3):94-9. PubMed ID: 128702
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of the hydrolysis of synthetic substrates by horse urinary kallikrein and trypsin.
    Sampaio MU; Galembeck F; Paiva AC; Prado ES
    Gen Pharmacol; 1976 Aug; 7(2-3):167-71. PubMed ID: 987954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of kinin, kallidin, and bradykinin.
    HOLDSTOCK DJ; MATHIAS AP; SCHACHTER M
    Br J Pharmacol Chemother; 1957 Jun; 12(2):149-58. PubMed ID: 13446366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptides.
    Claeson G; Fareed J; Larsson C; Kindel G; Arielly S; Simonsson R; Messmore HL; Balis JU
    Adv Exp Med Biol; 1979; 120B():691-713. PubMed ID: 517262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bradykinin and Kallidin].
    HOLTZ P; HEICKE B; BARCK S
    Experientia; 1962 Apr; 18():184-5. PubMed ID: 13908606
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
    Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional analysis of a novel bradykinin inhibitory peptide in the venoms of New World Crotalinae pit vipers.
    Graham RL; Graham C; McClean S; Chen T; O'Rourke M; Hirst D; Theakston D; Shaw C
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1587-92. PubMed ID: 16277978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
    Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
    Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRADYKININOGEN, ANGIOTENSINOGEN AND KALLIDINOGEN.
    FASCIOLO JC
    Br J Pharmacol Chemother; 1963 Oct; 21(2):250-8. PubMed ID: 14081656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural characterization of lipopeptide agonists for the bradykinin B2 receptor.
    Giragossian C; Nardi E; Savery C; Pellegrini M; Meini S; Maggi CA; Papini AM; Mierke DF
    Biopolymers; 2001 Apr; 58(5):511-20. PubMed ID: 11241222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of rabbit corpus cavernosum relaxation mediated by the tissue kallikrein-kinin system.
    Lopes-Martins RA; Antunes E; Oliva ML; Sampaio CA; Burton J; de Nucci G
    Br J Pharmacol; 1994 Sep; 113(1):81-6. PubMed ID: 7529116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin.
    ROCHA E SILVA M; BERALDO WT; ROSENFELD G
    Am J Physiol; 1949 Feb; 156(2):261-73. PubMed ID: 18127230
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic bradykinin: its biological identity with natural pure trypsin bradykinin.
    KONZETT H; STUERMER E
    Nature; 1960 Dec; 188():998. PubMed ID: 13753030
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the bradykinin forming principle of snake venom].
    HOLTZ P; RAUDONAT HW; CONTZEN C
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 239():54-67. PubMed ID: 14402883
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the primary structure of bovine high-molecular-weight kininogen. Amino acid sequence of a fragment ("histidine-rich peptide") released by plasma kallikrein.
    Han YN; Komiya M; Iwanaga S; Suzuki T
    J Biochem; 1975 Jan; 77(1?):55-68. PubMed ID: 1169237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.